Alisha B Arrigo

USPTO Granted Patents = 7 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 38(Granted Patents)

Company Filing History:

Constellation Pharmaceuticals, Inc.

patents

Years Active: 2016-2020

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10813936 - Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-YL)-pyrazolo[1,5-A]pyrimidin-3-YL)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate (2020-10-27),

2. 10799505 - Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate (2020-10-13),

3. 10577350 - Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (2020-03-03),

4. 10285993 - Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate (2019-05-14),

5. 10172861 - Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate (2019-01-08),

6. 9782414 - Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate (2017-10-10),

7. 9278936 - Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride (2016-03-08),

Title: Alisha B Arrigo: Innovator in Pharmaceutical Crystallization

Introduction

Alisha B Arrigo is a prominent inventor based in Boulder, Colorado, known for her significant contributions to the field of pharmaceuticals. With a total of seven patents to her name, she has made remarkable strides in the development of novel crystalline forms of pharmaceutical compounds. Her work focuses on improving the efficacy and stability of medications used in treating various medical conditions.

Latest Patents

One of Alisha's latest patents involves a crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-YL)-pyrazolo[1,5-A]pyrimidin-3-YL)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate. This innovative crystalline form is designed for use in pharmaceutical compositions aimed at treating pain, cancer, inflammation, neurodegenerative diseases, and infections. The patent also details a stable polymorph of the compound and outlines a process for its preparation, showcasing her expertise in pharmaceutical crystallization.

Career Highlights

Throughout her career, Alisha has worked with notable companies in the pharmaceutical industry, including Array Biopharma Inc. and Constellation Pharmaceuticals, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects, further enhancing her skills as an inventor.

Collaborations

Alisha has collaborated with esteemed colleagues such as Derrick Juengst and Khalid Ali Shah. These partnerships have contributed to her success in the field and have fostered an environment of innovation and creativity.

Conclusion

Alisha B Arrigo is a trailblazer in the pharmaceutical industry, with a focus on developing novel crystalline forms that enhance drug efficacy. Her contributions through her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.